GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Ryvu Therapeutics SA (WAR:RVU) » Definitions » FCF Yield %

Ryvu Therapeutics (WAR:RVU) FCF Yield % : -8.92 (As of Jun. 23, 2024)


View and export this data going back to 2011. Start your Free Trial

What is Ryvu Therapeutics FCF Yield %?

FCF Yield % is calculated as Free Cash Flow divided by Market Capitalization. It is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

As of today, Ryvu Therapeutics's Trailing 12-Month Free Cash Flow is zł-103.31 Mil, and Market Cap is zł1,158.30 Mil. Therefore, Ryvu Therapeutics's FCF Yield % for today is -8.92%.

The historical rank and industry rank for Ryvu Therapeutics's FCF Yield % or its related term are showing as below:

WAR:RVU' s FCF Yield % Range Over the Past 10 Years
Min: -36.54   Med: -7.13   Max: 1.23
Current: -8.92


During the past 13 years, the highest FCF Yield % of Ryvu Therapeutics was 1.23%. The lowest was -36.54%. And the median was -7.13%.

WAR:RVU's FCF Yield % is ranked better than
61.03% of 1550 companies
in the Biotechnology industry
Industry Median: -14.395 vs WAR:RVU: -8.92

Ryvu Therapeutics's FCF Margin % for the quarter that ended in Mar. 2024 was -203.77%.


Ryvu Therapeutics FCF Yield % Historical Data

The historical data trend for Ryvu Therapeutics's FCF Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Ryvu Therapeutics FCF Yield % Chart

Ryvu Therapeutics Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
FCF Yield %
Get a 7-Day Free Trial Premium Member Only Premium Member Only -5.76 -4.96 -6.33 1.33 -7.01

Ryvu Therapeutics Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
FCF Yield % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -9.89 -7.43 -2.48 -7.22 -13.80

Competitive Comparison of Ryvu Therapeutics's FCF Yield %

For the Biotechnology subindustry, Ryvu Therapeutics's FCF Yield %, along with its competitors' market caps and FCF Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Ryvu Therapeutics's FCF Yield % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Ryvu Therapeutics's FCF Yield % distribution charts can be found below:

* The bar in red indicates where Ryvu Therapeutics's FCF Yield % falls into.



Ryvu Therapeutics FCF Yield % Calculation

FCF Yield % is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

Ryvu Therapeutics's FCF Yield % for the fiscal year that ended in Dec. 2023 is calculated as

FCF Yield %=Free Cash Flow / Market Cap
=-93.129 / 1329.40575
=-7.01%

Ryvu Therapeutics's annualized FCF Yield % for the quarter that ended in Mar. 2024 is calculated as

FCF Yield %=Free Cash Flow * Annualized Factor / Market Cap
=-44.027 * 4 / 1276.21296
=-13.80%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Ryvu Therapeutics FCF Yield % Explanation

Similar to Earnings Yield %, FCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high free cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.


Ryvu Therapeutics FCF Yield % Related Terms

Thank you for viewing the detailed overview of Ryvu Therapeutics's FCF Yield % provided by GuruFocus.com. Please click on the following links to see related term pages.


Ryvu Therapeutics (WAR:RVU) Business Description

Traded in Other Exchanges
N/A
Address
Leona Henryka Sternbacha 2, Krakow, POL, 30-394
Ryvu Therapeutics SA is a company which is engaged in discovering and developing small molecule therapies that address oncology. Its product candidate SEL120, is a kinase inhibitor with potential for development in hematological malignancies and solid tumors. The pipeline products of the company are developed in the areas of kinases, cancer metabolism, synthetic lethality, and immuno-oncology pathways.

Ryvu Therapeutics (WAR:RVU) Headlines

No Headlines